Intel inside is about to take on a whole new biological meaning, as the worlds of information technology and biomedical science collide.
Intel Chief Technology Officer Justin Rattner says the firmís research and development teams are making breakthroughs using semiconductors to synthesize and study disease-associated proteins.
[Get a 10% discount on ARM TechCon 2012 conference passes by using promo code EDIT. Click here to learn about the show and register.]
Rattner said people didnít expect to see Intel in the biomedical field, but described the ongoing research being done alongside Stanford Universityís medical center as "very important." A paper on the study has already been published in Nature of Medicine journal.
The researchers have been synthesizing short segments of biological proteins, called peptides, on silicon wafers using some of the same methods used in semiconductor manufacturing, including sequential steps of light exposure and photolithography.
The chip, dubbed an Intel array by researchers, can analyze thousands of protein interactions simultaneously, allowing it to detect those associated with certain diseases and their variations. This in turn makes it easier for doctors to determine what drugs would be most effective for a particular patient, assess various therapies and for researchers to design ever more-effective drugs.
Understanding how proteins interact within the human body is something that has historically taken a lot of time, so this research is something of a breakthrough in terms of getting results in at very high speeds.
Diagnosing diseases like Lupus used to be very hard, sometimes taking years, but Rattner said this new system allows doctors to take blood samples and have results back "literally in a matter of minutes."
Rattner called the progress a "brave new world by anybodyís measure," noting that it's not just a question of collecting the data and crunching some numbers, but having information technology and biotechnology physically meet. "Thatís very exciting," he said.
"Weíre getting to the point where information technology and biotechnology are getting up close and personal and it just promises great things for healthcare," he added.
Another disease that could be more decisively diagnosed and treated using this method is arthritis. With over 30 different types of arthritis, doctors can have a tough time knowing which particular variation a person is suffering from.
"Most doctors will never actually know which one a patient has, until we can identify the different types of proteins associated with the different types of arthritis," Rattner explained.
The best most patients can currently hope for is to get a prescription for anti-inflammatories, but Rattner said in the near future, physicians would be able to know exactly what type of arthritis they are dealing with, and which specific treatments are needed to treat it.
"Thatís what this fusion of information technology and biotechnology will give us," he said.
Intel into bionics. The biometric world has infinite opportunities and here with Intel's new technology it seems with over 30 different types of arthritis physicians would be able to know exactly what type of arthritis they are dealing with.Then treating it is very specific and cure is faster.
Custom diagnosis and treatment is the way modern medecine is heading and ICT is playing a major role in this already. I think we will one day have micro and nano agents embedded in our bodies which can be programmed adaptively to fight off emerging diseases. The equivalent of going to a doctor would be a simple matter of scanning one's body to download the latest anti-illness programme :-)
David Patterson, known for his pioneering research that led to RAID, clusters and more, is part of a team at UC Berkeley that recently made its RISC-V processor architecture an open source hardware offering. We talk with Patterson and one of his colleagues behind the effort about the opportunities they see, what new kinds of designs they hope to enable and what it means for todayís commercial processor giants such as Intel, ARM and Imagination Technologies.